Amedeo Smart

Free Medical Literature Service


 

Amedeo

Prostate Cancer

  Free Subscription

Articles published in
Am J Pathol
    August 2024
  1. BRANDT MP, Vakhrusheva O, Hackl H, Daher T, et al
    Inhibition of the sterol regulatory element binding protein (SREB-P) SREBF-1 overcomes docetaxel resistance in advanced prostate cancer.
    Am J Pathol. 2024 Aug 19:S0002-9440(24)00295.
    >> Share

    July 2024
  2. HAN X, Zhang A, Wang P, Bi H, et al
    Pleckstrin-2 mediates the activation of AKT in prostate cancer and is repressed by androgen receptor.
    Am J Pathol. 2024 Jul 26:S0002-9440(24)00246.
    >> Share

    December 2023
  3. CULIG Z, Puhr M
    Androgen receptor interacting proteins in prostate cancer development and therapy resistance.
    Am J Pathol. 2023 Dec 15:S0002-9440(23)00461.
    >> Share

    June 2023
  4. ZHANG Y, Li W, Guo S, Wu Z, et al
    FBXO22 mediates the NGF/TRKA signaling pathway in bone metastases in prostate cancer.
    Am J Pathol. 2023 Jun 8:S0002-9440(23)00204-3. doi: 10.1016/j.ajpath.2023.
    >> Share

  5. HANDLE F, Puhr M, Gruber M, Andolfi C, et al
    The oncogenic protein kinase/ATPase RIOK1 is up-regulated via the MYC/E2F transcription factor axis in prostate cancer.
    Am J Pathol. 2023 Jun 8:S0002-9440(23)00205-5. doi: 10.1016/j.ajpath.2023.
    >> Share

    February 2023
  6. ROY A, Prasad S, Chen Y, Chao Y, et al
    Protein kinase D2 and 3 promote prostate cancer cell bone metastasis by positively regulating Runx2 in a MEK/ERK1/2-dependent manner.
    Am J Pathol. 2023 Feb 3:S0002-9440(23)00036-6. doi: 10.1016/j.ajpath.2023.
    >> Share

    January 2023
  7. YU YP, Liu S, Ren BG, Nelson J, et al
    Fusion Gene Detection in Prostate Cancer Samples Enhances the Prediction of Prostate Cancer Clinical Outcomes from Radical Prostatectomy through Machine Learning in a Multi-institutional Analysis.
    Am J Pathol. 2023 Jan 18:S0002-9440(23)00029.
    >> Share

    October 2022
  8. LOW JY, Ko M, Hanratty B, Patel RA, et al
    Genomic Characterization of Prostatic Basal Cell Carcinoma.
    Am J Pathol. 2022 Oct 26. pii: S0002-9440(22)00320.
    >> Share

    June 2022
  9. MURESAN XM, Slabakova E, Prochazkova J, Drapela S, et al
    Toll-like receptor 3 (TLR3) overexpression induces invasion of prostate cancer cells, whereas its activation triggers apoptosis.
    Am J Pathol. 2022 Jun 21. pii: S0002-9440(22)00174.
    >> Share

    February 2022
  10. OFFERMANN A, Joerg V, Becker F, Roesch MC, et al
    Inhibition of CDK8/CDK19 suppresses its pro-oncogenic effects in prostate cancer.
    Am J Pathol. 2022 Feb 15. pii: S0002-9440(22)00047.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016